Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Cash from Financing Activities (2010 - 2026)

Repligen's (RGEN) quarterly Cash from Financing Activities came in at -$6.2 million in Q2 2026, up 38.8% year-over-year from -$4.5 million in Q2 2025, and down 11.85% quarter-over-quarter from -$5.5 million in Q1 2026.

Analysis

Repligen (RGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Cash from Financing Activities for 17 consecutive years, with -$6.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 38.8% year-over-year to -$6.2 million in Q2 2026; TTM through Jun 2026 was -$11.8 million, a 85.85% increase from a year earlier, with the FY2025 full-year figure at -$15.2 million, up 81.66% from the prior year.
  • Cash from Financing Activities was -$6.2 million for Q2 2026 at Repligen, down from -$5.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $268.1 million in Q4 2023 and troughed at -$69.6 million in Q3 2024.
  • A 5-year average of $7.0 million and a median of -$5.3 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 97956.57% in 2023 and tumbled 8846.53% in 2024, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at -$274000.0 in 2022, then jumped by 97956.57% to $268.1 million in 2023, then plunged by 99.46% to $1.4 million in 2024, then slumped by 86.54% to $195000.0 in 2025, then plunged by 3279.49% to -$6.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$6.2 million (Q2 2026), -$5.5 million (Q1 2026), and $195000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -1.57 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 7.27 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 471.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -129.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -23.16 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -33.21 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -27.60 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -6.20 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.02 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 149.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.20 Mn
Mar 31, 2026 -5.54 Mn
Dec 31, 2025 195,000.00
Sep 30, 2025 -239,000.00
Jun 30, 2025 -10.13 Mn
Mar 31, 2025 -5.03 Mn
Dec 31, 2024 1.45 Mn
Sep 30, 2024 -69.60 Mn
Jun 30, 2024 -5.77 Mn
Mar 31, 2024 -8.97 Mn
Dec 31, 2023 268.13 Mn
Sep 30, 2023 -778,000.00
Jun 30, 2023 -8.83 Mn
Mar 31, 2023 -9.56 Mn
Dec 31, 2022 -274,000.00
Sep 30, 2022 1.25 Mn
Jun 30, 2022 -2.29 Mn
Mar 31, 2022 -12.02 Mn
Dec 31, 2021 231,000.00
Sep 30, 2021 -122,000.00